top of page
Founded in 2021 AlonBio brings together the culture and energy of a start-up biotech company with seasoned experienced leadership in developing cancer medicines to create the next generation targeted oncology company.
We are science-driven Our internal drug screening platforms, led by our scientific team, combined with our development capabilities, have the potential to transform targeted cancer treatment and provide hope for difficult to treat advanced cancer patients.
Excellent science and innovation are the keys for development of novel cancer therapies
Expand our targeted anti-cancer approach to improve and extend the life of patients with advanced cancers
bottom of page